c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer’s disease
Abstract Background Alzheimer’s disease (AD) is an incurable, debilitating neurodegenerative disorder. Current biomarkers for AD diagnosis require expensive neuroimaging or invasive cerebrospinal fluid sampling, thus precluding early detection. Blood-based biomarker discovery in Alzheimer’s can faci...
Main Authors: | Sherlyn Jemimah, Aamna AlShehhi, for the Alzheimer’s Disease Neuroimaging Initiative |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-023-01675-9 |
Similar Items
-
Predicting early Alzheimer’s with blood biomarkers and clinical features
by: Muaath Ebrahim AlMansoori, et al.
Published: (2024-03-01) -
Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease
by: Sepehr Golriz Khatami, et al.
Published: (2022-04-01) -
Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergies
by: Muhammad Usman Sadiq, et al.
Published: (2022-01-01) -
Detection of Alzheimer’s Disease Using Logistic Regression and Clock Drawing Errors
by: Sophia Lazarova, et al.
Published: (2023-07-01) -
Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
by: Sherlyn Jemimah, et al.
Published: (2023-01-01)